158 PTK6 inhibition potentiates the effects of the EGFR antibody cetuximab and the small tyrosine kinase inhibitors on pancreatic carcinoma cell lines proliferation

Autor:	P. Caruana, Miguel Saceda, J.A. Encinar-Hidalgo, M. Poveda-Delltel, G. Fernandez-Ballester, P. Garcia-Morales, Isabel Martínez-Lacaci, P. Lucero-Calabuig
Rok vydání:	2015
Předmět:	Cancer Research Oncology Cetuximab business.industry Cell culture Cancer research Medicine PTK6 Pancreatic carcinoma business Tyrosine kinase EGFR Antibody medicine.drug
Zdroj:	European Journal of Cancer. 51:S16-S17
ISSN:	0959-8049
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::581a23d39cf07d3f501ac20fbe50a605 https://doi.org/10.1016/s0959-8049(16)30055-7 Zobrazit plný text záznamu Full Text from ScienceDirect